Marshall Financial Group LLC Sellas Life Sciences Group, Inc. Transaction History
Marshall Financial Group LLC
- $458 Million
- Q3 2025
A detailed history of Marshall Financial Group LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Marshall Financial Group LLC holds 10,309 shares of SLS stock, worth $18,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,309
Previous 10,309
-0.0%
Holding current value
$18,762
Previous $22,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
90Shares Held
22.8MCall Options Held
1.3MPut Options Held
59.3K-
Vanguard Group Inc Valley Forge, PA6.65MShares$12.1 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.72MShares$4.94 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$4 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.49MShares$2.71 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.13MShares$2.05 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $37.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...